No article text was recorded for this version.
cross-platform expression validation
Version 1 of 151 papers52 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Potential biomarkers of acute myocardial infarction based on co‑expression network analysis
- Blog: An improvement of ComiR algorithm for microRNA target prediction by exploiting coding region sequences of mRNAs
- Blog: Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
- Blog: The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma
- Blog: Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15
- Blog: Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer
- Blog: Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types
- Blog: GREM1 is a potential biomarker for the progression and prognosis of bladder cancer
- Blog: Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment
- Blog: MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma
- Blog: Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma
- Blog: Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
- Blog: Exportin-T Promotes Breast Cancer Progression via PI3K/AKT/mTOR Signaling Pathway
- Blog: SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer
- Blog: The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors
- Blog: Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis
- Blog: The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
- Blog: The human secretome
- Blog: Clinical significance and effect of PRR 11 up-regulation on the malignancy of osteosarcoma
- Blog: Nucleotide Metabolism and Immune Genes Can Predict the Prognostic Risk of Hepatocellular Carcinoma and the Immune Microenvironment
- Blog: Analysis of transcript and protein overlap in a human osteosarcoma cell line
- Blog: ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma
- Blog: SH3 domain‑binding glutamic acid‑rich protein‑like 3 is associated with hyperglycemia and a poor outcome in Epstein‑Barr virus‑negative gastric carcinoma
- Blog: CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression
- Blog: Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis
- Blog: Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
- Blog: Machine learning for identifying tumor stemness genes and developing prognostic model in gastric cancer
- Blog: Global Survey of Human T Leukemic Cells by Integrating Proteomics and Transcriptomics Profiling
- Blog: Stathmin 1 expression in neuroendocrine and proliferating prostate cancer
- Blog: Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia
- Blog: Deciphering ERR family genes as prognostic and immunological biomarkers through pan-cancer analysis with validation in gallbladder cancer
- Blog: Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas
- Blog: Expression of Aquaporin Water Channels in the Rat Pituitary Gland
- Blog: Network analysis of an in vitro model of androgen-resistance in prostate cancer
- Blog: Decreased Expression of Retinoblastoma Protein-Interacting Zinc-Finger Gene 1 Is Correlated With Poor Survival and Aggressiveness of Cervical Cancer Patients
- Blog: Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer
- Blog: Klotho is regulated by transcription factor Sp1 in renal tubular epithelial cells
- Blog: Gene DSCC1 is a Potential Biomarker in Pan-cancer
- Blog: Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia
- Blog: Unveiling the Prognostic Power and Immune Landscape of MyD88 in Breast Cancer: an Integrative Bioinformatics and IHC Approach
- Blog: Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
- Blog: Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer
- Blog: High-pH reversed-phase fractionated neural retina proteome of normal growing C57BL/6 mouse
- Blog: Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro
- Blog: Integrated expression profiles of mRNA and microRNA in the liver of Fructus Meliae Toosendan water extract injured mice
- Blog: Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer
- Blog: Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker
- Blog: Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
- Blog: Identification of novel genes whose expression in adipose tissue affects body fat mass and distribution: an RNA-Seq and Mendelian Randomization study
- Blog: Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses
- Blog: CLDN18.2 expression and its impact on prognosis and the immune microenvironment in gastric cancer
History & citation
Current · Permanent link
- This direction split from Integrative Multi-omics Validation of Disease Biomarkers (55% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_cross_platform_expression_validation_5ebeaf23,
title = {cross-platform expression validation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/cross-platform-expression-validation/rdr_5ebeaf237d2e42209f026c58c31e326d},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_cross_platform_expression_validation_5ebeaf23_v1,
title = {cross-platform expression validation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/cross-platform-expression-validation/rdr_5ebeaf237d2e42209f026c58c31e326d/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}